Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD)
Gespeichert in:
| Deutscher übersetzter Titel: | Akute Toxizität und Entzugssyndrome im Zusammenhang mit Gamma-Hydroxybutyrat (GHB) und seiner Analoga Gamma-Butyrolacton (GBL) und 1,4-Butanediol (1,4-BD) |
|---|---|
| Autor: | Wood, David M.; Brailsford, Alan D.; Dargan, Paul I. |
| Erschienen in: | Drug testing and analysis |
| Veröffentlicht: | 3 (2011), 7/8 (New psychoactive substances), S. 417-425, Lit. |
| Format: | Literatur (SPOLIT) |
| Publikationstyp: | Zeitschriftenartikel |
| Medienart: | Gedruckte Ressource Elektronische Ressource (online) |
| Sprache: | Englisch |
| ISSN: | 1942-7603, 1942-7611 |
| DOI: | 10.1002/dta.292 |
| Schlagworte: | |
| Online Zugang: | |
| Erfassungsnummer: | PU201111009753 |
| Quelle: | BISp |
Abstract
Gamma-hydroxybutyrate (GHB) has been used as a recreational drug since the 1990s and over the last few years there has been increasing use of its analogues gamma-butyrolactone (GBL) and to a lesser extent 1,4-butanediol (1,4BD). This review will summarize the literature on the pharmacology of these compounds; the patterns and management of acute toxicity associated with their use; and the clinical patterns of presentation and management of chronic dependency associated with GHB and its analogues. Verf.-Referat